Pharmacy Automation Robotics Market : Global Industry Analysis and Opportunity Assessment, 2036

How big is Pharmacy Automation Robotics Market in 2026?

USD 6.0 billion in 2026 and USD 14.2 billion by 2036 at a 9.0% CAGR.

Sales in pharmacy automation robotics market are projected to increase from USD 6.0 billion in 2026 to USD 14.2 billion by 2036 at a 9.0% CAGR. Hospital systems are evaluating robotics as a way to protect pharmacist time without reducing clinical review. The USA Bureau of Labor Statistics reported in August 2025 that pharmacists earned a median annual wage of USD 137,480 in May 2024. This labor cost strengthens the financial case for automated storage and retrieval at high-volume sites. The broader pharmacy automation outlook shows why investment decisions increasingly combine labor savings with medication safety and service continuity.

Investment economics differ between the United States and the United Kingdom due to different labor and facility cost structures. The USA Bureau of Labor Statistics reported in April 2026 that pharmacy technicians earned a median annual wage of USD 43,460 in May 2024. The January 2025 UK impact assessment estimated that a large automated hub serving up to 200 spokes could cost GBP 5 million to GBP 8 million. Health systems must compare staffing exposure with building work and service coverage prior to equipment approval. An integrated medication management system improves the investment case by coordinating inventory and dispensing across several locations.

Summary of the Pharmacy Automation Robotics Market

Market Signal	Commercial Impact
Demand and Growth Drivers	Labor pressure and prescription volume are turning automation into capacity protection for pharmacies that cannot add staff at the same pace as demand. Robotic storage and retrieval systems reduce manual shelf searches and release pharmacist time for prescription review or patient counseling during busy service periods. Centralized fulfillment gives several hospital or retail locations access to one controlled inventory pool that can operate beyond normal site staffing hours. Cloud-connected dispensing applies consistent inventory rules across central pharmacies and care units and preserves local clinical approval for each medication decision. Sterile compounding robots support repeatable preparation records and controlled handling in facilities that manage hazardous drugs or recurring intravenous dose volumes.
Product and Segment View	Capital spending remains concentrated in physical systems due to the installed equipment and controlled medication movement required by every automated workflow. Dispensing robots is anticipated to account for 42.0% of product revenue in 2026 as high-volume sites seek faster storage and retrieval. Central hospital pharmacies is forecast to represent 38.0% of application revenue through consolidated medication handling for several inpatient and outpatient care areas. Hardware represents an estimated 58.0% of component spending in 2026 due to robots and storage modules that require facility installation and service access. Software gains commercial weight following installation by controlling inventory rules and device alerts across a growing network of pharmacy equipment.
Geography and Growth Outlook	National adoption differs according to hospital investment capacity and the maturity of digital prescription workflows within each pharmacy system. The United States is projected to expand at 10.0% CAGR through multi-site health systems that can spread equipment costs across greater volume. Germany and Japan combine established pharmacy infrastructure with demand for labor efficiency and detailed prescription traceability.
Competitive Landscape	Workflow coverage shapes competition as pharmacy operators need equipment and software to function as one dependable medication system across both hospital and retail settings. BD and Swisslog Healthcare compete in storage and unit-dose workflows that become part of routine hospital infrastructure through long installation cycles and daily service needs. Omnicell and ARxIUM combine automated dispensing with enterprise software and both companies maintain verified robotic intravenous compounding systems. YUYAMA and ScriptPro address prescription preparation through automated picking and vial filling for pharmacies with defined workflow requirements. Capsa Healthcare and Deenova cover central-fill automation and closed-loop hospital medication management across different medicine handling stages.
Analyst Perspective	Commercial success depends on whether robotics removes a real workflow bottleneck without creating a new integration burden elsewhere. Hospital systems should compare throughput and validation requirements with device prices because workflow design often determines realized savings. Retail chains need a clear plan for exceptions and stock reconciliation since reliable inventory information remains necessary throughout routine dispensing and stock control. Companies that support interfaces and staff training can reduce implementation risk across multi-site programs despite the capital burden from building changes and temporary capacity. - Anurag Sharma, Principal Analyst at Future Market Insights

Source: FMI's proprietary forecasting model and primary research

How is the pharmacy automation robotics market segmented?

The industry is assessed by product, application, component, end user, sales channel, and region.

The segmentation separates equipment economics from the pharmacy settings that determine operating value and capital priorities. Product analysis covers dispensing robots and intravenous compounding systems together with packaging equipment and automated storage. Application coverage compares central hospital pharmacy with retail dispensing and sterile preparation across different service requirements. Component analysis separates physical equipment from software and support services that control alerts or inventory rules. End-user coverage includes hospitals and retail chains together with long-term care and central-fill facilities with distinct operating requirements. Sales-channel analysis compares direct purchase with leasing and service contracts that shift capital exposure over time. Regional analysis explains how budgets and prescription workflows shape adoption across different national pharmacy systems. The final structure connects pharmacy equipment with hospital service robotics used for medication handling and internal logistics.

What supports demand for dispensing robots within the product category?

Dispensing robots address repeated picking and packaging work that limits daily pharmacy throughput during prescription peaks. YUYAMA MANUFACTURING CO., LTD. introduced RoboPick IIVC in June 2025 so pharmacy staff could change loaded medicines on site without tools. The feature reduces dependence on factory reconfiguration and supports more medicine types within one installed system across high-volume pharmacy operations at daily scale.

• By product, dispensing robots are projected to represent 42.0% of 2026 revenue through their fit with routine prescription volume. Automated picking reduces repeated shelf searches and preserves pharmacist review at the final dispensing stage. This balance gives high-volume pharmacies measurable throughput gains without forcing a complete redesign of every downstream task.
• Hospital outpatient pharmacies and retail chains are expected to favor systems that can handle medicine changes and exception work. Selection depends on verified accuracy and responsive service across the full installed life rather than stated machine speed alone. Related pharmaceutical robotics systems create additional options for packaging and internal medicine movement within high-volume sites.

How does central hospital pharmacy shape demand within the application category?

Central hospital pharmacies combine high prescription volume with inventory controls that benefit from consolidated automation across several care units. The Fujian Provincial Health Commission reported in January 2025 that a fully automated intravenous compounding robot prepared each bottle in 35 to 70 seconds. This operating range shows how hospitals can standardize repeated sterile work and retain pharmacist oversight for final release and clinical review.

• In 2026, central hospital pharmacy is expected to account for 38.0% of application revenue through consolidated medication handling. Hospitals can connect storage and compounding equipment with one inventory process that supports inpatient and outpatient demand. Centralization raises the value of uptime; a single equipment interruption can affect medicine availability across several care areas and disrupt planned service.
• Health systems are evaluating automation for sterile doses and urgent prescription retrieval across inpatient and outpatient services. These applications need controlled links with pharmacy information systems and cleanroom procedures that govern sterile work. Hospital approval therefore depends on a practical validation plan and a clear fallback process for routine care during equipment downtime.

How is hardware positioned within the component category?

Hardware receives early capital because every automated workflow needs physical storage and controlled medication movement inside the pharmacy. ARxIUM reported in April 2026 that RIVA robotic compounding systems had prepared more than 19 million sterile doses in USP 797-compliant environments. This volume shows that installed equipment can support sustained daily production rather than a short demonstration or limited hospital pilot.

• By component, hardware is estimated to hold 58.0% share in 2026 due to the cost of robots and storage modules. Installation may need power upgrades and facility changes that place equipment within a multi-year capital plan. Service access and spare-part availability then influence the useful life and daily reliability of that investment.
• Software and services are expected to gain value as pharmacy networks monitor more equipment across several sites. Managers need inventory visibility and alert handling together with dependable mechanical throughput at every location. Companies that connect device data with daily operating decisions can earn recurring revenue well beyond the original hardware installation.

What are the drivers, restraints, and opportunities in the pharmacy automation robotics market?

Labor shortages support adoption. Facility investment slows projects. Connected medication workflows create recurring service revenue.

• Driver: Pharmacy labor pressure is expected to support robotic dispensing that transfers repeated storage and picking work from staff to controlled equipment.
• Restraint: Facility construction and workflow validation are anticipated to delay projects that cannot spread investment across several pharmacy locations.
• Opportunity: Connected platforms are projected to create recurring software and support revenue following installation of core robotic hardware across pharmacy operations.

Persistent labor pressure is shifting investment from isolated device replacement toward coordinated medication management across health systems. Omnicell announced Titan XT in December 2025 as an automated dispensing system built on its OmniSphere cloud platform. The launch extends centralized inventory controls into nursing care areas and supports consistent rules across several settings. Companies can gain recurring revenue as health systems purchase software support with installed equipment throughout long equipment lives. This model favors platforms that remain useful as a health system connects more care locations.

Capital requirements remain a practical barrier because automation can change the building and the pharmacy process at the same time. The United Kingdom issued hub-and-spoke dispensing regulations in June 2025 that require written operating arrangements and clear patient information. These obligations add planning work that must be completed prior to routine service from a shared automated hub. Project approval therefore depends on a realistic volume case and a tested continuity plan for medicine supply.

China shows how public hospital programs can create demand for domestic pharmacy robots and integration services. The Wuhan municipal government reported in April 2025 that a locally developed smart pharmacy system had reached more than 100 hospitals. Its replenishment robot processed over 800 medicine boxes per hour with a reported pick success rate above 99.999%. This operating evidence creates an opening for companies that connect physical automation with electronic batch records and hospital information systems.

Which country CAGRs are profiled in the pharmacy automation robotics market?

Country	CAGR
United States	10.0%
Japan	8.0%

Source: FMI's proprietary forecasting model and primary research.

How do country-level CAGRs compare in the pharmacy automation robotics market?

Country growth reflects the operating problem that automation must solve within each national pharmacy system. United States demand places greater weight on labor economics and multi-site systems with shared medication inventories. Japan relies on equipment companies familiar with medicine preparation routines. The outlook links physical equipment with clinical workflow solutions that coordinate medicine operations across several care settings. Replenishment decisions can draw on artificial intelligence inventory tools that support stock planning across pharmacy locations.

• United States health systems are consolidating pharmacy work across larger networks that can use shared automation across several sites. Labor availability remains a practical constraint for repeated dispensing and inventory work during busy operating periods. The sector is projected to record 10.0% CAGR from 2026 to 2036 through multi-site investment and higher prescription volume. The USA Bureau of Labor Statistics reported in April 2026 that about 49,000 pharmacy technician openings were projected each year from 2024 to 2034. This staffing gap supports equipment that transfers inventory and filling tasks from limited personnel to controlled systems. Service response and software compatibility shape investment decisions across networks that cannot tolerate downtime at several connected locations.
• Japan has an established base of dispensing equipment and detailed medicine preparation practices that support gradual automation. Local pharmacies often need systems that fit medicine formats and established checking routines without disrupting existing service. Sales are forecast to expand at 8.0% CAGR from 2026 to 2036 as pharmacies seek more staff time for patient care. YUYAMA MANUFACTURING CO., LTD. reported JPY 58.2 billion in sales for the fiscal year ending March 2026. The figure shows meaningful domestic scale across pharmaceutical automation and medication management equipment within established pharmacy networks. Local maintenance and careful configuration are likely to remain important selection factors for pharmacies with specialized preparation routines.

Who are the notable companies in the pharmacy automation robotics market?

BD, Omnicell, ARxIUM, Swisslog Healthcare, YUYAMA MANUFACTURING CO., LTD., ScriptPro LLC, Capsa Healthcare, and Deenova are notable companies in this industry.

Competition spans robotic storage and sterile compounding together with software that manages medication access across several sites. BD and Swisslog Healthcare address hospital storage through pharmacy robotics supported by installation and service programs. Omnicell and ARxIUM combine automated dispensing with enterprise software and verified robotic intravenous compounding systems. YUYAMA and ScriptPro serve defined prescription preparation tasks through picking or vial-filling equipment in hospital or retail pharmacies. Capsa Healthcare supports counting and central-fill work and Deenova focuses on closed-loop hospital medication management. Related connected drug cabinets increase the value of reliable software links across care areas and nursing units. Broader medical automation systems raise expectations for coordinated service across several equipment categories over time.

• BD and Swisslog Healthcare compete in projects that need high-density storage and controlled medicine retrieval. BD Rowa Vmax serves hospital-based and community pharmacies and Swisslog Healthcare offers BoxPicker storage and PillPick unit-dose equipment. Installation planning and service response affect commercial value once each system becomes part of daily hospital infrastructure.
• Omnicell and ARxIUM address enterprise medication management through automated dispensing cabinets and connected software platforms. Both companies maintain verified robotic intravenous compounding systems that support controlled sterile preparation inside hospital pharmacies. Hospitals comparing these portfolios should examine inventory control and care-unit access together with cleanroom validation and ongoing software support.
• YUYAMA MANUFACTURING CO., LTD. and ScriptPro LLC focus on prescription preparation through automated picking and vial filling. Their equipment suits pharmacies seeking targeted workflow improvement without adopting one enterprise platform across every routine medication task. Medicine format and prescription volume matter as much as local maintenance coverage during system selection.
• Capsa Healthcare and Deenova address different stages within medication preparation and administration workflows across pharmacy networks. Capsa Healthcare provides counting and central-fill systems and Deenova connects pharmacy work with ward-level medicine use through closed-loop technology. Pharmacy networks may add medication pouch inspection if packaged-dose verification becomes part of the operating design.

Competitive Benchmarking: Pharmacy Automation Robotics Market

Company	Dispensing Robotics	Sterile Compounding	Software Integration	Geographic Reach
BD	High	Low	High	High
Omnicell	High	High	High	High
ARxIUM	High	High	High	High
Swisslog Healthcare	High	Low	High	High
YUYAMA MANUFACTURING CO., LTD.	High	High	High	Medium
ScriptPro LLC	High	Low	High	Medium
Capsa Healthcare	High	Low	Medium	Medium
Deenova	High	Low	High	Medium

Scoring basis: Ratings reflect verified product scope and software coverage across the exact pharmacy automation categories shown. The assessment also considers sterile compounding capability and official operating regions for each company in the benchmark. High indicates broad verified coverage across the assessed categories; Medium indicates selective coverage and Low indicates limited verified coverage.

Source: Future Market Insights

Key Developments in the Pharmacy Automation Robotics Market

• In September 2025, BD, announced a pharmacy automation partnership with Henry Ford Health to install BD Rowa Vmax storage and retrieval systems across hospital-based community pharmacies in Michigan. The first use case provides prescription retrieval throughout the day and night at participating locations. The agreement shows how one health system can apply the same robotic platform across several sites with coordinated service support.
• In December 2025, ARxIUM, introduced MedSelect Aspire automated dispensing cabinets with expanded storage and connected medication management software. The product extends ARxIUM beyond central pharmacy equipment and sterile compounding into secure access workflows across care areas. Hospitals gain another option for applying common inventory rules and medication controls across a wider equipment network. This broader coverage can reduce the number of separate systems used across medication access points.
• In September 2025, Swisslog Healthcare, formed a partnership with Diligent Robotics to add Moxi delivery robots to hospital logistics programs. Swisslog reported that Moxi had completed more than 300,000 pharmacy deliveries within over one million total hospital deliveries. The partnership connects central pharmacy automation with last-mile transport that can reduce staff travel between preparation areas and care units. Hospitals can use this link to extend automation beyond the pharmacy door without changing core medication controls.
• In January 2025, Capsa Healthcare, launched the Kirby Lester KL1v prescription counting device for routine pharmacy filling. The product supports accurate tablet counting and repeatable preparation within community or retail pharmacy settings. The launch shows continued investment in compact automation that improves a defined dispensing step without the building changes associated with a large central-fill project. This product category remains relevant for pharmacies that need measured improvement within a limited physical footprint.

Key Players in the Pharmacy Automation Robotics Market

Hospital storage and unit-dose automation

• BD
• Swisslog Healthcare
• Deenova

Retail and central-fill dispensing robotics

• YUYAMA MANUFACTURING CO., LTD.
• ScriptPro LLC
• Capsa Healthcare

Enterprise dispensing and sterile compounding

• Omnicell
• ARxIUM

Pharmacy Automation Robotics Market - Report Scope

Coverage field	Report scope
Market breakdown	Product, application, component, end user, sales channel, and region.
Quantitative units	Revenue in USD million or USD billion. Shares and growth rates are percentages.
Market definition	Robotic systems that store, retrieve, count, package, compound, or dispense medicines within pharmacy operations.
Regions covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East and Africa.
Countries covered	United States, Canada, Germany, United Kingdom, France, China, Japan, India, Australia, Brazil, and selected regional countries.
Key companies profiled	BD, Omnicell, ARxIUM, Swisslog Healthcare, YUYAMA MANUFACTURING CO., LTD., ScriptPro LLC, Capsa Healthcare, and Deenova.
Forecast period	The assessment covers 2026 to 2036 with historical context from 2024 onward.
Coverage	Market sizing is combined with segment analysis, country comparison, workflow economics, adoption barriers, and competitive positioning.

Pharmacy Automation Robotics Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing and Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

Pharmacy Automation Robotics Market by Segments

By Product

• Dispensing robots
• IV compounding robots
• Packaging and pouch systems
• Storage and retrieval systems

By Application

• Central hospital pharmacy
• Retail dispensing
• Sterile compounding
• Mail-order and central-fill

By Component

• Hardware
• Software
• Services

By End User

• Hospital pharmacies
• Retail pharmacy chains
• Long-term care pharmacies
• Central-fill facilities

By Sales Channel

• Direct purchase
• Lease
• Service contract
• Pilot program

Pharmacy Automation Robotics Market by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Nordic countries
• East Asia
  • China
  • Japan
  • South Korea
• South Asia
  • India
  • ASEAN countries
  • Oceania
  • Australia
  • New Zealand
• Middle East and Africa
  • GCC countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• ABDA. (2026, January 13). 2025 pharmacy count falls to 16,601 operating sites.
• Apollo Hospitals Enterprise Limited. (2025, August). Annual Report 2024-25.
• ARxIUM. (2026, April 30). RIVA surpasses 19 million doses safely prepared in USP 797-compliant
• ARxIUM. (2025, December 1). ARxIUM launches MedSelect Aspire automated dispensing cabinets.
• BD. (2025, September 22). BD and Henry Ford Health sign pharmacy automation partnership.
• Beijing Municipal Foreign Affairs Office. (2025, September 3). Pakistani Prime Minister Shehbaz Sharif visits Tongzhou Campus of Beijing Anzhen Hospital and praises its smart pharmacy.
• Capsa Healthcare. (2025, January 8). Capsa Healthcare unveils the Kirby Lester KL1v.
• Capsa Healthcare. (n.d.). Central-fill and mail-order pharmacy automation solutions.
• Deenova. (2026, June 22). Deenova to deliver an integrated medication management platform at Policlinico di Milano.
• Fujian Provincial Health Commission. (2025, January 15). Fujian introduces its first fully automated intravenous compounding robot.
• Omnicell. (2025, December 8). Omnicell announces Titan XT automated dispensing system. Automated-Dispensing-System-Designed-to-Empower-Autonomous-Medication-Management/default.aspx
• Omnicell. (n.d.). IVX Station automated intravenous compounding robot.
• Swisslog Healthcare. (n.d.). Pharmacy automation and systems.
• Swisslog Healthcare. (2025, September 15). Swisslog Healthcare partners with Diligent Robotics.
• United Kingdom Department of Health and Social Care. (2025, January 30). Extension of hub and spoke dispensing to different legal entities: Final impact assessment.
• United Kingdom Government. (2025, June 25). The Human Medicines Regulations 2025: Hub and spoke dispensing amendments.
• USA Bureau of Labor Statistics. (2025, August 28). Pharmacists: Occupational Outlook Handbook.
• USA Bureau of Labor Statistics. (2026, April 24). Pharmacy technicians: Occupational Outlook Handbook.
• Wuhan Municipal Government. (2025, April 8). Smart pharmacy automatic replenishment technology reaches hospitals across China.
• YUYAMA MANUFACTURING CO., LTD. (2025, June 1). RoboPick IIVC on-site medicine change feature.

This bibliography is provided for reader reference and uses primary government, standards-body, official trade body, and company sources.

This Report Answers

• How large is the pharmacy automation robotics industry in 2026 and what value is forecast for 2036?
• Which product and application categories account for the greatest share of 2026 revenue?
• How do labor economics and prescription volume influence investment in robotic dispensing systems?
• What limits adoption among smaller hospitals and independent community pharmacies?
• How do country growth paths differ across China and the United States?
• Which verified companies supply dispensing systems and sterile compounding or storage robotics?
• How should pharmacy operators compare equipment with software and service requirements?
• What commercial opportunity comes from connecting robots with enterprise medication information?
• Which recent company developments are changing competition within pharmacy automation robotics?